# US 6,727,272 B1 · Leflunomide analogs for treating rheumatoid arthritis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,272 B1
- Document ID: US6727272B1
- Status: Granted
- Kind: B1
- Application number: 10/195,824
- Filed: 2002-07-15
- Granted: 2004-04-27
- Earliest claimed: 2002-07-15
- Assignees: Unitech Pharmaceuticals, Inc.
- Inventors: An-Rong Lee; Wen-Hsin Huang; Jiajiu Shaw
- Web page: https://patentgrep.com/patent/US6727272B1

## CPC

- C07D 261/18: Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Novel leflunomide analogs were synthesized and evaluated in-vivo. Based on the in-vivo studies, these analogs are surprisingly effective for treating rheumatoid arthritis.

## Claims

### Claim 1

A compound of the formula (I)
or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br, 2,4-(Br)2, 3-CF3, 4CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br.

### Claim 2

A pharmaceutical composition comprising a compound of the formula (I)
or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br, 2,4-(Br)2, 3-CF3, 4-CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br.

### Claim 3

A method of treating rheumatoid arthritis comprising administering to a patient an effective amount of a pharmaceutical composition comprising a compound of the formula (I)
or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br, 2,4-(Br)2, 2-CF3, 3-CF3, 4-CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 2-OCH3, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br.

### Claim 4

A method of treating rheumatoid arthritis comprising administering to a patient a therapeutically effective amount of a composition comprising a compound of the formula (I)
or a physiological tolerable salt of the compound of the formula (I), wherein R is —H, 2-Cl, 3-Cl, 4-Cl, 2,4-(Cl)2, 2-F, 3-F, 4-F, 2,4-(F)2, 2-Br, 3-Br, 4-Br,2,4-(Br)2, 2-CF3, 3-CF3, 4-CF3, 2,4-(CF3)2, 2-COOH, 3-COOH, 4-COOH, 2,4-(COOH)2, 2-OCH3, 3-OCH3, 4-OCH3, 3,4,5-(OCH3)3, 2-NH—CO—CH2Cl, 4-NH—CO—CH2Cl, 2-NH—CO—CH2Br, or 4-NH—CO—CH2Br, and a drug selected from the group consisting of dexamethasone, ibuprofen, leflunomide, malononitrilamide, diclofenac sodium, diclofenac potassium, naproxen, naproxen sodium, and combinations thereof.

### Claim 5 (depends on 1)

The compound of claim 1 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 3-CF3, 4-CF3, 2,4-(Cl)2, 4-OCH3, 3,4,5-(OCH3)3, 4-COOH, or 4-F.

### Claim 6 (depends on 1)

The compound of claim 1 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 4-CF3, 2,4-(Cl)2, 4-COOH, or 4-F.

### Claim 7 (depends on 1)

The compound of claim 1 wherein R is 2-Cl, 4-Cl, or 2,4-(Cl)2.

### Claim 8 (depends on 1)

The compound of claim 1 wherein R is 2-Cl.

### Claim 9 (depends on 1)

The compound of claim 1 wherein R is 4-Cl.

### Claim 10 (depends on 1)

The compound of claim 1 wherein R is 2,4-(Cl)2.

### Claim 11 (depends on 2)

The pharmaceutical composition of claim 2 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 3-CF3, 4-CF3, 2,4-(Cl)2, 4-OCH3, 3,4,5-(OCH3)3, 4-COOH, or 4-F.

### Claim 12 (depends on 2)

The pharmaceutical composition of claim 2 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 4-CF3, 2,4-(Cl)2, 4-COOH, or 4-F.

### Claim 13 (depends on 2)

The pharmaceutical composition of claim 2 wherein R is 2-Cl, 4-Cl, or 2,4-(Cl)2.

### Claim 14 (depends on 2)

The pharmaceutical composition of claim 2 wherein R is 2-Cl.

### Claim 15 (depends on 2)

The pharmaceutical composition of claim 2 wherein R is 4-Cl.

### Claim 16 (depends on 2)

The pharmaceutical composition of claim 2 wherein R is 2,4-(Cl)2.

### Claim 17 (depends on 3)

The method of claim 3 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 3-CF3, 4-CF3, 2,4-(Cl)2, 4-OCH3, 3,4,5-(OCH3)3, 4-COOH, or 4-F.

### Claim 18 (depends on 3)

The method of claim 3 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 4-CF3, 2,4-(Cl)2, 4-COOH, or 4-F.

### Claim 19 (depends on 3)

The method of claim 3 wherein R is 2-Cl, 4-Cl, or 2,4-(Cl)2.

### Claim 20 (depends on 3)

The method of claim 3 wherein R is 2-Cl.

### Claim 21 (depends on 3)

The method of claim 3 wherein R is 4-Cl.

### Claim 22 (depends on 3)

The method of claim 3 wherein R is 2,4-(Cl)2.

### Claim 23 (depends on 4)

The method of claim 4 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 3-CF3, 4-CF3, 2,4-(Cl)2, 4-OCH3, 3,4,5-(OCH3)3, 4-COOH, or 4-F.

### Claim 24 (depends on 4)

The method of claim 4 wherein R is H, 2-Cl, 3-Cl, 4-Cl, 4-CF3, 2,4-(Cl)2, 4-COOH, or 4-F.

### Claim 25 (depends on 4)

The method of claim 4 wherein R is 2-Cl, 4-Cl, or 2,4-(Cl)2.

### Claim 26 (depends on 4)

The method of claim 4 wherein R is 2-Cl.

### Claim 27 (depends on 4)

The method of claim 4 wherein R is 4-Cl.

### Claim 28 (depends on 4)

The method of claim 4 wherein R is 2,4-(Cl)2.
